TABLE OF CONTENTS FIGURES AND TABLES PART 1. INTRODUCTION 1.1 Description 1.2 Objectives of The Study 1.3 Market Segment 1.4 Years Considered for The Report 1.5 Currency 1.6 Key Target Audience PART 2. RESEARCH METHODOLOGY 2.1 Primary Research 2.2 Secondary Research PART 3. EXECUTIVE SUMMARY PART 4. MARKET OVERVIEW 4.1 Introduction 4.2 Drivers 4.3 Restraints PART 5. GLOBAL TRANSCRIPTOMICS MARKET BY COMPONENT 5.1 Consumables 5.2 Instruments 5.3 Software PART 6. GLOBAL TRANSCRIPTOMICS MARKET BY TECHNOLOGY 6.1 Next-generation sequencing 6.2 Polymerase chain reaction 6.3 Microarray 6.4 Mass cytometry 6.5 Others PART 7. GLOBAL TRANSCRIPTOMICS MARKET BY APPLICATION 7.1 Drug discovery and development 7.2 Diagnostics 7.3 Cell biology 7.4 Single cell analysis 7.5 Gene expression 7.6 Others PART 8. GLOBAL TRANSCRIPTOMICS MARKET BY END USER 8.1 Academic 8.2 Pharmaceutical companies 8.3 Others PART 9. GLOBAL TRANSCRIPTOMICS MARKET BY REGION 9.1 North America 9.2 Europe 9.3 Asia-Pacific 9.4 MEA (Middle East and Africa) 9.5 Latin America PART 10. COMPANY PROFILES 10.1 Pacific Biosciences of California, Inc. 10.2 Thermo Fisher Scientific, Inc. 10.3 Agilent Technologies, Inc. 10.4 Illumina, Inc. 10.5 QIAGEN, N.V. 10.6 Bio-Rad Laboratories, Inc. 10.7 Takara Bio Inc. 10.8 PerkinElmer Inc. 10.9 Standard BioTools Inc. 10.10 10x Genomics, Inc. 10.11 NanoString Technologies, Inc. 10.12 Becton, Dickinson and Company (BD) 10.13 Bio-Techne Corporation 10.14 Pall Corporation 10.15 BioSpyder Technologies Inc. 10.16 ANGLE plc 10.17 Menarini Silicon Biosystems S.p.A. DISCLAIMER